| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |